Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic aberrations in non- small cell lung cancer and their impact on treatment outcome.

Journal of cancer research and therapeutics - 1 Jan 2000

Mohammed Amrallah A, El-Tanni Hani, Alsakkaf Mohammed A, Mirza Ahmad A, Atiah Tariq Al-Malki, Atiah Arwa Al-Malki

Abstract excerpt

The therapeutic options of nonsmall cell lung cancer (NSCLC) therapy has been changed since the first discovery of activating epidermal growth factor receptor (EGFR) mutations and the development of specific EGFR tyrosine kinase inhibitors, which resulted in the evolution of "personalized medicine." There are a considerable number of genomic aberrations in NSCLC serving as potential predictive biomarkers and drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genome, Human

Share to Genomics

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Treatment Outcome

Source

Identifiers

PMID: 28508826
DOI: 10.4103/0973-1482.180605

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic aberrations in non- small cell lung cancer and their impact on treatment outcome.PMID 28508826Read ↗

Genetic Alterations in NSCLC: Prognostic Implications and Impact on Therapeutic Resistance.Semantic proximity Read ↗

[Molecular profiling of non-small cell lung cancer].Semantic proximity Read ↗

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapySemantic proximity Read ↗

IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.Semantic proximity Read ↗

Chromosomal and genomic changes in lung cancerSemantic proximity Read ↗

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.Semantic proximity Read ↗

Molecular Targets Beyond the Big 3.Semantic proximity Read ↗

Genomic architecture of lung cancers.Semantic proximity Read ↗

The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future DirectionsSemantic proximity Read ↗

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacySemantic proximity Read ↗

Molecular genetic profiling of small cell lung carcinoma in a Chinese cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.